Paweł Madej

medical university of silesia in katowice

H指数:22

被引数:1,458

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical Obesity and Insulin Resistance Assessed Based on SHBG Levels and HOMA-IR, TyG-Waist Circumference (TyG-WC), TyG-Waist to Height Ratio (TyG-WHtR), and TyG-Waist to Hip Ratio (TyG-WHR) Values in Young Caucasian Women with Polyendocrine Metabolic Ovarian Syndrome (PMOS)

基于SHBG水平、HOMA-IR、TyG-腰围（TyG-WC）、TyG-腰高比（TyG-WHtR）和TyG-腰臀比（TyG-WHR）值评估年轻白人女性多内分泌代谢卵巢综合征（PMOS）的临床肥胖和胰岛素抵抗

Journal of Clinical Medicine

IF2.9

2026-09-170

Metabolic and Endocrine Alterations in Underweight and Normal-Weight Women with Functional Hypothalamic Amenorrhea

功能下丘脑闭经状态下体重过轻和体重正常女性的代谢与内分泌改变

Journal of Clinical Medicine 2025, Vol. 14, Page 7082

IF2.9

2025-10-070

OAAI

A 17-year-old girl with primary amenorrhea, adrenal insufficiency, and hypertension diagnosed with congenital adrenal hyperplasia due to 17 α-hydroxylase deficiency

一位17岁女孩，表现为原发性闭经、肾上腺功能不全和高血压，诊断为因17α-羟化酶缺乏所致的先天性肾上腺皮质增生症。

EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY

IF1.9

2025-09-250

PRE

The Cut-Off Value for the Triglyceride-Glucose Index (TyG) Discriminating Insulin Resistance Based on the SHBG Level and HOMA-IR Values in Women with Polycystic Ovary Syndrome

基于SHBG水平和HOMA-IR值的女性多囊卵巢综合征中，用于鉴别胰岛素抵抗的甘油三酯-葡萄糖指数(TyG)截断值

LIFE-BASEL

IF3.4

2025-04-230

Dietary Patterns and Metabolic and Hormonal Parameters in Women with Suspected PCOS

饮食模式与疑似PCOS女性患者的代谢及激素参数

JOURNAL OF CLINICAL MEDICINE

IF2.9

2025-04-150

Sexual Function in Women with Polycystic Ovary Syndrome Living in Stable Heterosexual Relationships: A Cross-Sectional Study

JOURNAL OF CLINICAL MEDICINE

IF2.9

2024-04-121

OAAI

A cross-sectional study of the association between circulating sex hormone-binding globulin levels and selected adipokines in women with polycystic ovary syndrome

FRONTIERS IN MEDICINE

IF3

2023-07-252

OAAI

Correlation between Selected Clinical Symptoms and Severity of Aggression, Impulsiveness and Their Selected Behavioral Manifestations in Patients with Polycystic Ovary Syndrome Phenotype A

METABOLITES

IF3.7

2023-05-091

OAAI

The cut-off value for HOMA-IR discriminating the insulin resistance based on the SHBG level in women with polycystic ovary syndrome

FRONTIERS IN MEDICINE

IF3

2023-03-1010

OAAI

Liver phenotypes in PCOS: Analysis of exogenous and inherited risk factors for liver injury in two European cohorts

LIVER INTERNATIONAL

IF5.2

2023-02-053

OAAI

Flow predictability indicates the ecological quality of the river: A case of invertebrates in Central Europe

流量可预测性表明河流的生态质量: 中欧无脊椎动物的案例

ECOLOGICAL INDICATORS

IF7.4

2022-10-019

OAAI

Clinical Usefulness of Non-Invasive Metabolic-Associated Fatty Liver Disease Risk Assessment Methods in Patients with Full-Blown Polycystic Ovary Syndrome in Relation to the MRI Examination with the Ideal IQ Sequence

BIOMEDICINES

IF3.9

2022-09-050

OAAI

Macroinvertebrate habitat requirements in rivers: overestimation of environmental flow calculations in incised rivers

HYDROLOGY AND EARTH SYSTEM SCIENCES

IF5.8

2022-08-088

Evaluation of Pro/Antioxidant Imbalance in Blood of Women with Polycystic Ovary Syndrome Based on Determination of Oxidized Low-Density Lipoproteins and Ferric Reducing Ability of Plasma Values

BIOMEDICINES

IF3.9

2022-06-307

OAAI

The Activity of Superoxide Dismutase, Its Relationship with the Concentration of Zinc and Copper and the Prevalence of rs2070424 Superoxide Dismutase Gene in Women with Polycystic Ovary Syndrome-Preliminary Study

JOURNAL OF CLINICAL MEDICINE

IF2.9

2022-05-0118

OAAI

Body Composition and Its Impact on the Hormonal Disturbances in Women with Polycystic Ovary Syndrome

NUTRIENTS

IF5

2021-11-247

OAAI

The Associations between Sex Hormones and Lipid Profiles in Serum of Women with Different Phenotypes of Polycystic Ovary Syndrome

JOURNAL OF CLINICAL MEDICINE

IF2.9

2021-08-3111

OAAI

The role of proprotein convertase subtilisin/kexin type-9 concentration and paraoxonase 1 activities in the blood of women with polycystic ovary syndrome

ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY

IF4.2

2021-05-015

PREAI

Circulating anti-Mullerian hormone levels in relation to nutritional status and selected adipokines levels in polycystic ovary syndrome

CLINICAL ENDOCRINOLOGY

IF2.4

2015-02-0337

PREAI

Circulating FGF21 levels are related to nutritional status and metabolic but not hormonal disturbances in polycystic ovary syndrome

EUROPEAN JOURNAL OF ENDOCRINOLOGY

IF5.2

2015-02-0118

OAAI

Paweł Madej

个人简介

教育背景

工作经历

荣誉奖项

研究方向